TY - JOUR
T1 - Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma
AU - Mikoshiba, Takuya
AU - Ozawa, Hiroyuki
AU - Watanabe, Yoshihiro
AU - Kawaida, Miho
AU - Sekimizu, Mariko
AU - Saito, Shin
AU - Yoshihama, Keisuke
AU - Nakamura, Shintaro
AU - Nagai, Ryoto
AU - Imanishi, Yorihisa
AU - Kameyama, Kaori
AU - Ogawa, Kaoru
N1 - Funding Information:
We thank all the patients who participated in our study and Editage (www.editage.jp) for English language editing.
Publisher Copyright:
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
PY - 2022/1
Y1 - 2022/1
N2 - Objective: The histological grade of parotid gland carcinoma (PGC) is an important prognostic factor; however, the diagnosis prior to treatment has been challenging to make. This study aimed to investigate whether the pretreatment clinical findings, including hematological inflammatory, nutritional, and immune markers, could predict the histological grade of PGC. Study Design: Retrospective study. Methods: We retrospectively enrolled 111 patients with PGC and evaluated the correlation between histological grade and pretreatment clinical findings such as age, sex, tumor staging, facial nerve paralysis, pain or tenderness, adhesion to the surrounding tissues or tumor immobility, and hematological markers. Results: Sixty patients (54%) were diagnosed with histological high-grade PGC. Univariate analysis revealed that age, T classification, N classification, TNM stage, facial nerve paralysis, adhesion/immobility, C-reactive protein (CRP), and CRP-to-albumin ratio (CAR) were significant predictors of PGC histological grade. On multivariate analysis, high T classification (T3, 4), high N classification (≥1), and elevated CRP (≥0.22 mg/dL) were independent predictors of high-grade PGC. Conclusions: Pretreatment T classification, N classification, and CRP are significant predictors of the histological grading of PGC. Our results are useful for treatment planning and obtaining appropriate informed consent from the patients before treatment. Level of Evidence: 4 Laryngoscope, 132:96–102, 2022.
AB - Objective: The histological grade of parotid gland carcinoma (PGC) is an important prognostic factor; however, the diagnosis prior to treatment has been challenging to make. This study aimed to investigate whether the pretreatment clinical findings, including hematological inflammatory, nutritional, and immune markers, could predict the histological grade of PGC. Study Design: Retrospective study. Methods: We retrospectively enrolled 111 patients with PGC and evaluated the correlation between histological grade and pretreatment clinical findings such as age, sex, tumor staging, facial nerve paralysis, pain or tenderness, adhesion to the surrounding tissues or tumor immobility, and hematological markers. Results: Sixty patients (54%) were diagnosed with histological high-grade PGC. Univariate analysis revealed that age, T classification, N classification, TNM stage, facial nerve paralysis, adhesion/immobility, C-reactive protein (CRP), and CRP-to-albumin ratio (CAR) were significant predictors of PGC histological grade. On multivariate analysis, high T classification (T3, 4), high N classification (≥1), and elevated CRP (≥0.22 mg/dL) were independent predictors of high-grade PGC. Conclusions: Pretreatment T classification, N classification, and CRP are significant predictors of the histological grading of PGC. Our results are useful for treatment planning and obtaining appropriate informed consent from the patients before treatment. Level of Evidence: 4 Laryngoscope, 132:96–102, 2022.
KW - C-reactive protein
KW - N classification
KW - Parotid gland carcinoma
KW - T classification
KW - high-grade carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85109998475&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109998475&partnerID=8YFLogxK
U2 - 10.1002/lary.29728
DO - 10.1002/lary.29728
M3 - Article
C2 - 34245171
AN - SCOPUS:85109998475
SN - 0023-852X
VL - 132
SP - 96
EP - 102
JO - Laryngoscope
JF - Laryngoscope
IS - 1
ER -